Cargando…

Non-steroidal anti-inflammatory drugs and the risk of out-of-hospital cardiac arrest: a case–control study

AIMS: Non-steroidal anti-inflammatory drugs (NSAIDs), particularly selective COX-2 inhibitors, are associated with an increased risk of cardiovascular adverse events. However, the association between these drugs and out-of-hospital cardiac arrest with electrocardiogram-documented ventricular tachyca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bakhriansyah, Mohammad, Souverein, Patrick C, Klungel, Olaf H, de Boer, Anthonius, Blom, Marieke T, Tan, Hanno L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321960/ https://www.ncbi.nlm.nih.gov/pubmed/30107407 http://dx.doi.org/10.1093/europace/euy180

Ejemplares similares

Risk of myocardial infarction associated with non‐steroidal anti‐inflammatory drugs: Impact of additional confounding control for variables collected from self‐reported data
por: Bakhriansyah, Mohammad, et al.
Publicado: (2019)

Cyclo‐oxygenase selectivity and chemical groups of nonsteroidal anti‐inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBase
por: Bakhriansyah, Mohammad, et al.
Publicado: (2019)

Multiple categories of non-cardiac QT-prolonging drugs are associated with increased risk of out-of-hospital cardiac arrest: real-world data from a population-based study
por: Eroglu, Talip E, et al.
Publicado: (2021)

Gastrointestinal toxicity among patients taking selective COX‐2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case–control study
por: Bakhriansyah, Mohammad, et al.
Publicado: (2017)

Acetylsalicylic acid use is associated with reduced risk of out-of-hospital cardiac arrest in the general population: Real-world data from a population-based study
por: Eroglu, Talip E., et al.
Publicado: (2022)

Out‐of‐hospital cardiac arrest and differential risk of cardiac and non‐cardiac QT‐prolonging drugs in 37 000 cases
por: Eroglu, Talip E., et al.
Publicado: (2021)

Sulfonylurea antidiabetics are associated with lower risk of out‐of‐hospital cardiac arrest: Real‐world data from a population‐based study
por: Eroglu, Talip E., et al.
Publicado: (2021)

Opioid use is associated with increased out‐of‐hospital cardiac arrest risk among 40 000‐cases across two countries
por: Eroglu, Talip E., et al.
Publicado: (2021)

Sex differences in out-of-hospital cardiac arrest
por: Oving, Iris, et al.
Publicado: (2020)

Use of sodium-glucose cotransporter-2 inhibitors and the risk for sudden cardiac arrest and for all-cause death in patients with type 2 diabetes mellitus
por: Eroglu, Talip E, et al.
Publicado: (2022)

Differential effects on out-of-hospital cardiac arrest of dihydropyridines: real-world data from population-based cohorts across two European countries
por: Eroglu, Talip E, et al.
Publicado: (2019)

Association of beta-blockers and first-registered heart rhythm in out-of-hospital cardiac arrest: real-world data from population-based cohorts across two European countries
por: Barcella, Carlo A, et al.
Publicado: (2020)

Patterns of antiplatelet drug use after a first myocardial infarction during a 10‐year period
por: Yasmina, Alfi, et al.
Publicado: (2016)

Increased Risk of Sudden Cardiac Arrest in Obstructive Pulmonary Disease: A Case-Control Study
por: Warnier, Miriam Jacoba, et al.
Publicado: (2013)

Genetic, clinical and pharmacological determinants of out-of-hospital cardiac arrest: rationale and outline of the AmsteRdam Resuscitation Studies (ARREST) registry
por: Blom, M T, et al.
Publicado: (2014)

Women have lower chances than men to be resuscitated and survive out-of-hospital cardiac arrest
por: Blom, Marieke T, et al.
Publicado: (2019)

Individual-level income and out-of-hospital cardiac arrest survival in men and women
por: van Dongen, Laura H, et al.
Publicado: (2022)

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Correction to: Non-steroidal anti-inflammatory drugs and the risk of out-of-hospital cardiac arrest: a case–control study
Publicado: (2019)

Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study
por: Althunian, Turki A., et al.
Publicado: (2020)

Steroid treatment as anti-inflammatory and neuroprotective agent following out-of-hospital cardiac arrest: a randomized clinical trial
por: Obling, Laust Emil Roelsgaard, et al.
Publicado: (2022)

Management of first responder programmes for out-of-hospital cardiac arrest during the COVID-19 pandemic in Europe
por: Andelius, Linn, et al.
Publicado: (2021)

Gender-related factors and out-of-hospital cardiac arrest incidence in women and men: analysis of a population-based cohort study in the Netherlands
por: Smits, Robin L A, et al.
Publicado: (2022)

Health data research on sudden cardiac arrest: perspectives of survivors and their next-of-kin
por: Bak, Marieke A. R., et al.
Publicado: (2021)

Ethical aspects of sudden cardiac arrest research using observational data: a narrative review
por: Bak, Marieke A. R., et al.
Publicado: (2018)

Higher chances of survival to hospital admission after out-of-hospital cardiac arrest in patients with previously diagnosed heart disease
por: van Dongen, Laura H, et al.
Publicado: (2021)

Out-of-hospital cardiac arrest prognosis during the COVID-19 pandemic
por: Pranata, Raymond, et al.
Publicado: (2020)

Risk of out‐of‐hospital cardiac arrest in patients with epilepsy and users of antiepileptic drugs
por: Eroglu, Talip E., et al.
Publicado: (2022)

Risk of out‐of‐hospital cardiac arrest in antidepressant drug users
por: Eroglu, Talip E., et al.
Publicado: (2022)

Quality of reporting of drug exposure in pharmacoepidemiological studies
por: Hempenius, Mirjam, et al.
Publicado: (2020)

First-response treatment after out-of-hospital cardiac arrest: a survey of current practices across 29 countries in Europe
por: Oving, Iris, et al.
Publicado: (2019)

Drug exposure misclassification in pharmacoepidemiology: Sources and relative impact
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Data-driven sudden cardiac arrest research in Europe: Experts’ perspectives on ethical challenges and governance strategies
por: Bak, Marieke A.R., et al.
Publicado: (2023)

Comment on: Out-of-hospital cardiac arrest: the prospect of E‑CPR in the Maastricht region
por: Blom, M. T., et al.
Publicado: (2016)

European first responder systems and differences in return of spontaneous circulation and survival after out-of-hospital cardiac arrest: A study of registry cohorts
por: Oving, Iris, et al.
Publicado: (2020)

Out-of-hospital cardiac arrest
por: Commerford, PJ
Publicado: (2016)

Out-of-hospital cardiac arrest
por: Nolan, Jerry P., et al.
Publicado: (2023)

Defining the noninferiority margin and analysing noninferiority: An overview
por: Althunian, Turki A., et al.
Publicado: (2017)

Temporal variation in out-of-hospital cardiac arrest occurrence in individuals with or without diabetes
por: van Dongen, L.H., et al.
Publicado: (2021)

Amiodarone use and the risk of acute pancreatitis: Influence of different exposure definitions
por: Hempenius, Mirjam, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1bdagcatstbn603h2lfb6lt10r